2021年最新SCI期刊影响因子查询系统
DIABETES OBESITY & METABOLISM 期刊详细信息
基本信息
期刊名称 | DIABETES OBESITY & METABOLISM DIABETES OBESITY & METABOLISM |
---|---|
期刊ISSN | 1462-8902 |
期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1463-1326 |
是否OA | 否 |
出版商 | Wiley-Blackwell Publishing Ltd |
出版周期 | Monthly |
始发年份 | 1999 |
年文章数 | 375 |
最新影响因子 | 6.408(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学2区 | ENDOCRINOLOGY & METABOLISM 内分泌学与代谢2区 | 否 | 否 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 6.08 | 2.777 | 1.604 |
Medicine Internal Medicine |
3 / 120 | 97% |
|||
Biochemistry, Genetics and Molecular Biology Endocrinology |
8 / 118 | 93% |
|||
Medicine Endocrinology, Diabetes and Metabolism |
9 / 211 | 95% |
补充信息
自引率 | 12.00% |
---|---|
H-index | 99 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1462-8902%5BISSN%5D |
投稿指南
期刊投稿网址 | http://mc.manuscriptcentral.com/dom |
---|---|
收稿范围 | Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter. The journal also invites review articles that are balanced, comprehensive and provide new and/or critical analysis of any aspect of drug therapy (or non-pharmacological intervention) relevant to patients with diabetes, obesity or metabolic disorders. The journal will also consider publication of letters to the editor commenting on research already published in the journal, as well as manuscripts describing new hypotheses or clinical trial protocols. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |